{"id":"https://openalex.org/W7225157759","doi":"https://doi.org/10.1515/jbcpp-2026-0265","title":"Bexagliflozin: pharmacological profile and clinical applications of a sodium-glucose cotransporter 2 inhibitor","display_name":"Bexagliflozin: pharmacological profile and clinical applications of a sodium-glucose cotransporter 2 inhibitor","publication_year":2026,"publication_date":"2026-11-03","ids":{"openalex":"https://openalex.org/W7225157759","doi":"https://doi.org/10.1515/jbcpp-2026-0265","pmid":"https://pubmed.ncbi.nlm.nih.gov/42975136"},"language":"en","primary_location":{"id":"doi:10.1515/jbcpp-2026-0265","doi":"https://doi.org/10.1515/jbcpp-2026-0265","is_oa":false,"landing_page_url":"https://doi.org/10.1515/jbcpp-2026-0265","pdf_url":null,"source":{"id":"https://openalex.org/S2756415187","display_name":"Journal of Basic and Clinical Physiology and Pharmacology","issn_l":"0792-6855","issn":["0792-6855","2191-0286"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","medline","norway-1","poland-40","russia-white-list-2"],"host_organization":"https://openalex.org/P4310313990","host_organization_name":"De Gruyter","host_organization_lineage":["https://openalex.org/P4310313990"],"host_organization_lineage_names":["De Gruyter"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Basic and Clinical Physiology and Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5160496658","display_name":"Arsaniouss Gars","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I192633058","display_name":"University of Saint Joseph","ror":"https://ror.org/05m5j6s60","country_code":"US","type":"education","lineage":["https://openalex.org/I192633058"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Arsaniouss Gars","raw_affiliation_strings":["Department of Pharmaceutical Sciences , University of Saint Joseph , West Hartford , CT , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Sciences , University of Saint Joseph , West Hartford , CT , USA","institution_ids":["https://openalex.org/I192633058"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5160467672","display_name":"Abeeha Khan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I192633058","display_name":"University of Saint Joseph","ror":"https://ror.org/05m5j6s60","country_code":"US","type":"education","lineage":["https://openalex.org/I192633058"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Abeeha Khan","raw_affiliation_strings":["Department of Pharmaceutical Sciences , University of Saint Joseph , West Hartford , CT , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Sciences , University of Saint Joseph , West Hartford , CT , USA","institution_ids":["https://openalex.org/I192633058"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5160468312","display_name":"Sophia Kim","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sophia Kim","raw_affiliation_strings":["Avon High School , Avon , CT , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Avon High School , Avon , CT , USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5160530540","display_name":"Caleigh Dodge","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I192633058","display_name":"University of Saint Joseph","ror":"https://ror.org/05m5j6s60","country_code":"US","type":"education","lineage":["https://openalex.org/I192633058"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Caleigh Dodge","raw_affiliation_strings":["Department of Pharmaceutical Sciences , University of Saint Joseph , West Hartford , CT , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Sciences , University of Saint Joseph , West Hartford , CT , USA","institution_ids":["https://openalex.org/I192633058"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052008422","display_name":"Harmandeep Tinna","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Harmandeep Tinna","raw_affiliation_strings":["Yale School of Medicine , New Haven , CT , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Yale School of Medicine , New Haven , CT , USA","institution_ids":["https://openalex.org/I32971472"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022909952","display_name":"Zhao Li","orcid":"https://orcid.org/0000-0002-0095-3587","observed_orcids":["https://orcid.org/0000-0002-0095-3587"]},"institutions":[{"id":"https://openalex.org/I192633058","display_name":"University of Saint Joseph","ror":"https://ror.org/05m5j6s60","country_code":"US","type":"education","lineage":["https://openalex.org/I192633058"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Zhao Li","raw_affiliation_strings":["Department of Pharmaceutical Sciences , University of Saint Joseph , West Hartford , CT , USA"],"raw_orcid":"https://orcid.org/0000-0002-0095-3587","affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Sciences , University of Saint Joseph , West Hartford , CT , USA","institution_ids":["https://openalex.org/I192633058"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5047425905","display_name":"Anisha Gupta","orcid":"https://orcid.org/0000-0002-0276-9169","observed_orcids":["https://orcid.org/0000-0002-0276-9169"]},"institutions":[{"id":"https://openalex.org/I192633058","display_name":"University of Saint Joseph","ror":"https://ror.org/05m5j6s60","country_code":"US","type":"education","lineage":["https://openalex.org/I192633058"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anisha Gupta","raw_affiliation_strings":["Department of Pharmaceutical Sciences , University of Saint Joseph , West Hartford , CT , USA"],"raw_orcid":"https://orcid.org/0000-0002-0276-9169","affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Sciences , University of Saint Joseph , West Hartford , CT , USA","institution_ids":["https://openalex.org/I192633058"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2400,"currency":"EUR","value_usd":2712},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.86611296,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10198","display_name":"Heart Failure Treatment and Management","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bexagliflozin","display_name":"bexagliflozin","score":1.0},{"id":"https://openalex.org/keywords/sglt2-inhibitors","display_name":"SGLT2 inhibitors","score":0.9789999723434448},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9980000257492065},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.8309999704360962},{"id":"https://openalex.org/keywords/hba1c","display_name":"HbA1c","score":0.8109999895095825},{"id":"https://openalex.org/keywords/albuminuria","display_name":"albuminuria","score":0.8379999995231628},{"id":"https://openalex.org/keywords/chronic-kidney-disease","display_name":"chronic kidney disease","score":0.9890000224113464},{"id":"https://openalex.org/keywords/cardiovascular-safety","display_name":"cardiovascular safety","score":0.8059999942779541},{"id":"https://openalex.org/keywords/heart-failure","display_name":"heart failure","score":0.8920000195503235},{"id":"https://openalex.org/keywords/dapagliflozin","display_name":"dapagliflozin","score":0.8289999961853027},{"id":"https://openalex.org/keywords/sitagliptin","display_name":"sitagliptin","score":0.8420000076293945},{"id":"https://openalex.org/keywords/glimepiride","display_name":"glimepiride","score":0.9580000042915344},{"id":"https://openalex.org/keywords/cardiorenal-protection","display_name":"cardiorenal protection","score":0.6510000228881836}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8420000076293945},{"id":"https://openalex.org/C2777422806","wikidata":"https://www.wikidata.org/wiki/Q409898","display_name":"Dapagliflozin","level":4,"score":0.8183000087738037},{"id":"https://openalex.org/C2776174234","wikidata":"https://www.wikidata.org/wiki/Q974792","display_name":"Albuminuria","level":3,"score":0.5697000026702881},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.5663999915122986},{"id":"https://openalex.org/C2777538456","wikidata":"https://www.wikidata.org/wiki/Q311213","display_name":"Glycated hemoglobin","level":4,"score":0.5608999729156494},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.5594000220298767},{"id":"https://openalex.org/C2778198053","wikidata":"https://www.wikidata.org/wiki/Q181754","display_name":"Heart failure","level":2,"score":0.5590999722480774},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.5372999906539917},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.5209000110626221},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5105000138282776},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.5026999711990356},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.4909999966621399},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4284000098705292},{"id":"https://openalex.org/C2778176773","wikidata":"https://www.wikidata.org/wiki/Q2976049","display_name":"Drug class","level":3,"score":0.4018000066280365},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.39480000734329224},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.38929998874664307},{"id":"https://openalex.org/C2775887513","wikidata":"https://www.wikidata.org/wiki/Q5373824","display_name":"Empagliflozin","level":4,"score":0.3847000002861023},{"id":"https://openalex.org/C2778653478","wikidata":"https://www.wikidata.org/wiki/Q1054718","display_name":"Kidney disease","level":2,"score":0.3601999878883362},{"id":"https://openalex.org/C159641895","wikidata":"https://www.wikidata.org/wiki/Q108377937","display_name":"Renal function","level":2,"score":0.3529999852180481},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.320499986410141},{"id":"https://openalex.org/C2780091579","wikidata":"https://www.wikidata.org/wiki/Q9377","display_name":"Kidney","level":2,"score":0.31369999051094055},{"id":"https://openalex.org/C2779010597","wikidata":"https://www.wikidata.org/wiki/Q5166601","display_name":"Convoluted tubule","level":3,"score":0.2831000089645386},{"id":"https://openalex.org/C3020000205","wikidata":"https://www.wikidata.org/wiki/Q2412849","display_name":"Narrative review","level":2,"score":0.2757999897003174},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.2752000093460083},{"id":"https://openalex.org/C2910068830","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 Diabetes Mellitus","level":3,"score":0.2703999876976013},{"id":"https://openalex.org/C141341695","wikidata":"https://www.wikidata.org/wiki/Q2368661","display_name":"Surrogate endpoint","level":2,"score":0.2565000057220459},{"id":"https://openalex.org/C2777451236","wikidata":"https://www.wikidata.org/wiki/Q5030940","display_name":"Canagliflozin","level":4,"score":0.25589999556541443},{"id":"https://openalex.org/C2777099384","wikidata":"https://www.wikidata.org/wiki/Q3799239","display_name":"Heart failure with preserved ejection fraction","level":4,"score":0.25209999084472656}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1515/jbcpp-2026-0265","doi":"https://doi.org/10.1515/jbcpp-2026-0265","is_oa":false,"landing_page_url":"https://doi.org/10.1515/jbcpp-2026-0265","pdf_url":null,"source":{"id":"https://openalex.org/S2756415187","display_name":"Journal of Basic and Clinical Physiology and Pharmacology","issn_l":"0792-6855","issn":["0792-6855","2191-0286"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","medline","norway-1","poland-40","russia-white-list-2"],"host_organization":"https://openalex.org/P4310313990","host_organization_name":"De Gruyter","host_organization_lineage":["https://openalex.org/P4310313990"],"host_organization_lineage_names":["De Gruyter"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Basic and Clinical Physiology and Pharmacology","raw_type":"journal-article"},{"id":"pmid:42975136","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42975136","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of basic and clinical physiology and pharmacology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":31,"referenced_works":["https://openalex.org/W2069724389","https://openalex.org/W2146264128","https://openalex.org/W2626446274","https://openalex.org/W2900413769","https://openalex.org/W2908535040","https://openalex.org/W2939222610","https://openalex.org/W2945272854","https://openalex.org/W2948473814","https://openalex.org/W2956311553","https://openalex.org/W2974260792","https://openalex.org/W3003546904","https://openalex.org/W3021402700","https://openalex.org/W3081830235","https://openalex.org/W3088173406","https://openalex.org/W3089283105","https://openalex.org/W3186720525","https://openalex.org/W3193297191","https://openalex.org/W4283767189","https://openalex.org/W4293354639","https://openalex.org/W4298088197","https://openalex.org/W4308183941","https://openalex.org/W4323036378","https://openalex.org/W4327566691","https://openalex.org/W4383302901","https://openalex.org/W4385778629","https://openalex.org/W4387516147","https://openalex.org/W4389571899","https://openalex.org/W4390343105","https://openalex.org/W4393072771","https://openalex.org/W4394574658","https://openalex.org/W7160981214"],"related_works":["https://openalex.org/W3186720525","https://openalex.org/W4385778629","https://openalex.org/W4283767189","https://openalex.org/W6902270765","https://openalex.org/W4387516147","https://openalex.org/W4409537542","https://openalex.org/W4385493337","https://openalex.org/W3035239421","https://openalex.org/W2945272854","https://openalex.org/W4236245991"],"abstract_inverted_index":{"Abstract":[0],"Bexagliflozin,":[1],"approved":[2],"in":[3,7,107],"the":[4,10,154,196],"United":[5],"States":[6],"2023,":[8],"is":[9,157],"fifth":[11],"selective":[12],"sodium-glucose":[13],"cotransporter":[14],"2":[15,20],"(SGLT2)":[16],"inhibitor":[17],"for":[18,60,112,147,183],"type":[19],"diabetes":[21],"mellitus":[22],"(T2DM).":[23],"Unlike":[24],"other":[25],"class":[26,52,77,177],"members,":[27],"it":[28,122],"lacks":[29],"an":[30,158],"event-driven":[31],"cardiovascular":[32,134,141],"outcomes":[33],"trial":[34,136],"(CVOT)":[35],"and":[36,55,69,75,81,94,100,137,166,172,190],"trials":[37,80,194],"with":[38,153],"hard":[39,191],"kidney":[40,120,192],"or":[41],"heart":[42,167],"failure":[43,168],"endpoints.":[44],"This":[45],"narrative":[46],"mini-review":[47],"separates":[48],"bexagliflozin-specific":[49],"evidence":[50],"from":[51,176],"benefits.":[53],"PubMed":[54],"Google":[56],"Scholar":[57],"were":[58,83,144,151],"searched":[59],"English-language":[61],"articles":[62],"(January":[63],"2009\u2013June":[64],"2026)":[65],"using":[66],"\u201cbexagliflozin,\u201d":[67],"\u201cBrenzavvy,\u201d":[68],"\u201cSGLT2":[70],"inhibitor,\u201d":[71],"plus":[72],"prescribing":[73],"information":[74],"pivotal":[76],"trials.":[78],"Randomized":[79],"meta-analyses":[82],"prioritized.":[84],"Bexagliflozin":[85,156],"reduced":[86,123],"glycated":[87],"hemoglobin":[88],"(HbA":[89],"1c":[90,114],"),":[91],"body":[92],"weight,":[93],"systolic":[95],"blood":[96],"pressure":[97],"vs.":[98,128],"placebo":[99],"was":[101],"noninferior":[102],"to":[103],"sitagliptin,":[104],"glimepiride,":[105],"and,":[106],"one":[108],"24-week":[109],"trial,":[110],"dapagliflozin":[111],"HbA":[113],".":[115],"In":[116],"stage":[117],"3a/3b":[118],"chronic":[119],"disease,":[121],"albuminuria":[124],"by":[125],"20.1":[126],"%":[127],"placebo,":[129],"a":[130],"surrogate":[131],"finding.":[132],"A":[133],"safety":[135],"meta-analysis":[138],"excluded":[139],"excess":[140],"risk":[142],"but":[143,162],"not":[145],"powered":[146,188],"benefit.":[148],"Adverse":[149],"events":[150],"consistent":[152],"class.":[155],"effective":[159],"glucose-lowering":[160],"drug,":[161],"its":[163],"cardiovascular,":[164],"kidney,":[165],"benefits":[169],"remain":[170],"unproven":[171],"cannot":[173],"be":[174],"assumed":[175],"data.":[178],"Outcome-proven":[179],"agents":[180],"are":[181,195],"preferred":[182],"cardiorenal":[184],"protection.":[185],"An":[186],"adequately":[187],"CVOT":[189],"endpoint":[193],"key":[197],"research":[198],"priorities.":[199]},"counts_by_year":[],"updated_date":"2026-11-05T12:25:35.769452","created_date":"2026-11-04T00:00:00"}